113 related articles for article (PubMed ID: 32440925)
21. Deregulated expression of cry1 and cry2 in human gliomas.
Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
[TBL] [Abstract][Full Text] [Related]
22. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
23. Specific V-ATPase expression sub-classifies IDHwt lower-grade gliomas and impacts glioma growth in vivo.
Terrasi A; Bertolini I; Martelli C; Gaudioso G; Di Cristofori A; Storaci AM; Formica M; Bosari S; Caroli M; Ottobrini L; Vaccari T; Vaira V
EBioMedicine; 2019 Mar; 41():214-224. PubMed ID: 30737087
[TBL] [Abstract][Full Text] [Related]
24. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiles for insular low-grade gliomas with putamen involvement.
Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
[TBL] [Abstract][Full Text] [Related]
26. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
[TBL] [Abstract][Full Text] [Related]
27. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
[TBL] [Abstract][Full Text] [Related]
29. Coiled-coil domain containing 109B is a HIF1α-regulated gene critical for progression of human gliomas.
Xu R; Han M; Xu Y; Zhang X; Zhang C; Zhang D; Ji J; Wei Y; Wang S; Huang B; Chen A; Zhang Q; Li W; Sun T; Wang F; Li X; Wang J
J Transl Med; 2017 Jul; 15(1):165. PubMed ID: 28754121
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of FRAT1 is associated with malignant phenotype and poor prognosis in human gliomas.
Guo G; Zhong CL; Liu Y; Mao XG; Zhang Z; Jin J; Liu J; Yang L; Mao JM; Guo YH; Zhao YL
Dis Markers; 2015; 2015():289750. PubMed ID: 25922553
[TBL] [Abstract][Full Text] [Related]
31. Gab2 expression in glioma and its implications for tumor invasion.
Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
[TBL] [Abstract][Full Text] [Related]
32. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
33. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
34. Is H3 K27M mutation testing relevant in the diagnostic routine of WHO grade 4 gliomas exclusively located in the corpus callosum in adults?
Paoli C; Segard S; Burel-Vandenbos F
J Neurooncol; 2021 Dec; 155(3):383-384. PubMed ID: 34800209
[No Abstract] [Full Text] [Related]
35. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
36. In vivo Metabolic Profiles as Determined by
Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of SEMA3B gene silencing and clinical significance in glioma.
Pang CH; Du W; Long J; Song LJ
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050958
[TBL] [Abstract][Full Text] [Related]
39. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
Huang RQ; Shi DL; Huang W; Chen F; Lu YC
J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]